Plexium, Inc., a biopharmaceutical company based in San Diego, CA, specializes in next-generation targeted protein degradation modalities for the treatment of cancer, neurodegeneration, and other diseases. “I was on a tight timeline when searching for a new sample management software partner,” says Nicole Anderson, Head of Compound Management at Plexium. She continues: “I was impressed by the caliber of the Xavo team and their excitement about the recent innovations in their software. Since launching Xavo, even complex workflows execute efficiently.”
Leveraging Xavo's rapid deployment capabilities, comprehensive out-of-the-box product functionality, and preconfigured integrations, the joint team successfully launched the sample management platform within a short timeframe.
“At Xavo, we take pride in demonstrating our ability to successfully deliver our solutions quickly even under stringent time constraints. Configuration and implementation of the Xavo R3 platform is a matter of days to weeks rather than months. The successful deployment at Plexium demonstrates the maturity of our product and the agility of our processes” says Florian Tauchert, Xavo’s Managing Director.
About the Xavo platform
Xavo R3 is a full-featured Sample Management and Lab Operations platform for Biopharma R&D labs that is exclusively offered as Software-as-a-Service. Xavo R3 tackles the dynamic challenges of today’s labs by using extendable business rules, algorithmic intelligence for lab equipment usage optimization as well as guided workflow support that prioritizes material use, throughput, cycle time and resource efficiency. Our machine learning algorithms ensure precise scheduling and quick issue resolution for streamlined workflows, making Xavo R3 the copilot for Life Sciences R&D labs.